Earn CME: https://www.naccme.com/program/19-lm-11 In this webcast from the ‘Moving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma: Understanding the PI3K Inhibitors’ symposium during the 2019 Lymphoma & Myeloma conference in New York, Drs. Martin, Casulo, Fischer, Cheson, and Haberman discuss the treatment of lymphoma on a panel discussion. © 2019 Imedex, an HMP Company
Follicular Lymphoma Panel Discussion
